Science ❯ Biotechnology ❯ Genetics

Gene Therapy

Clinical Trials Duchenne Muscular Dystrophy SIRT6 Gene Lipid Nanoparticles Personalized Medicine Rare Diseases Ethical Implications Sickle Cell Disease CRISPR Technology Adeno-Associated Virus (AAV)

Vertex Projects Casgevy Sales Above $100 Million in 2025 as CRISPR Therapeutics Waits for Payoff

Casgevy’s months-long, center-based treatment model is slowing early sales.